bcma-logo1-1
10th -
11th
September 2024 | 
SUNTEC SINGAPORE CONVENTION & EXHIBITION CENTRE

Biomanufacturing Excellence at Enhanced Speed & Superior Quality

10th -
11th
September 2024 | 
SUNTEC SINGAPORE CONVENTION & EXHIBITION CENTRE
📆 Add to Google Calendar
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

Concept

Ebook website cover 900 x 480 5
[E-Book]Biologics CMO Atlas: Navigating Biologics Contract Manufacturing in APAC

In 2023, the global biopharma CMO market size reached USD 17.41 billion, with projections to attain USD 39.31 billion by 2031, showcasing a dominant CAGR of 10.72%. Meanwhile, the global CDMO market size stands at USD 15.32 billion in 2024 and has a forecasted growth to USD 27.94 billion by 2029 at a CAGR of 12.78%.

While North America has traditionally dominated the CMO/CDMO market, the Asia Pacific region has emerged as the fastest-growing. Anticipated to experience a robust regional CAGR of 8.94% from 2024 to 2029, this growth is attributed to a rapidly expanding population driving demand for biolog-ics. Additional contributing factors include comparatively lower labour costs (as much as 30% lower in manufacturing alone), government policies and regulatory changes.

The 3rd Biologics Contract Manufacturing Asia 2024 is a premium event that focuses exclusively on Contract Manufacturing in Asia-Pacific. The conference addresses the growing market of contract manufacturing, the predicted trends in the market, challenges faced by CMOs/ CDMOs, as well as the solutions and opportunities moving forward. We bring the entire eco-system together — from experts in the biologics manufacturing space, to academia and regulatory — to foster partnerships, share insights and stay on the cutting edge of new developments.

Concept - Biologics Digitalization & AI World

The Digitalisation and Al presence in the Global Biopharma Industry is valued at approximately USD 1784.1 Million in 2022 and is expected to exhibit a robust growth rate exceeding 5.7% 2023 to 2030. It is expected to reach $2.47 Billion by 2027.

Meanwhile, the APAC market is catching up rapidly with digitalisation as many corporates are adopting technology in their research, manufacturing and supply chain initiatives. Governments including the nations of Singapore, China, Australia, South Korea, Japan, India, Taiwan to mention a few, offer strategic incentives for biomanufacturing, promoting investment, technology adoption infrastructure development and supportive regulations to bolster the region's biopharmaceutical manufacturing capabilities.

The event this year hence features a focused track on Biologics Digitalisation & AI on the first day, 10th of September. This congregation would be a platform to meet the leaders from the Biologics World of APAC, who have pioneered in adopting AI & Digitalisation in the R&D, Manufacturing/Bioprocessing, Quality, Compliance and Supply Chain aspects to improve the efficiency of processes, productivity and to reduce cost while bringing best in quality.

Concept - Biologics Digitalization & AI World

The Digitalisation and Al presence in the Global Biopharma Industry is valued at approximately USD 1784.1 Million in 2022 and is expected to exhibit a robust growth rate exceeding 5.7% 2023 to 2030. It is expected to reach $2.47 Billion by 2027.

Meanwhile, the APAC market is catching up rapidly with digitalisation as many corporates are adopting technology in their research, manufacturing and supply chain initiatives. Governments including the nations of Singapore, China, Australia, South Korea, Japan, India, Taiwan to mention a few, offer strategic incentives for biomanufacturing, promoting investment, technology adoption infrastructure development and supportive regulations to bolster the region's biopharmaceutical manufacturing capabilities.

The event this year hence features a focused track on Biologics Digitalisation & AI on the first day, 10th of September. This congregation would be a platform to meet the leaders from the Biologics World of APAC, who have pioneered in adopting AI & Digitalisation in the R&D, Manufacturing/Bioprocessing, Quality, Compliance and Supply Chain aspects to improve the efficiency of processes, productivity and to reduce cost while bringing best in quality.

FEATURED CONTENT

Ebook website cover 900 x 480 2
Biologics Contract Manufacturing & Biologics Digitalisation - Survey Results
Ebook website cover 900 x 480 5
Biologics CMO Atlas: Navigating Biologics Contract Manufacturing in APAC
Screenshot-2023-06-01-150634
E-Book: Exclusive Conversations with Key Biologics CMOs in China
e0f666c4-4f55-4fb6-80c5-d94f55689fb7
BCMA 2023 Survey Results
speaker-feature-1-website
BCMA22 Speaker Interview 1
Biologics Contract Manufacturing Asia 2024 and Biologics Digitalization & AI World 2024

.

.

.

.

.

.

.

.

.
.
.
.
.

THANK YOU TO OUR SUPPORTING PARTNERS









Biologics Contract Manufacturing Asia 2024 and Biologics Digitalization & AI World 2024

ADVISORY BOARD

Abhishek-Mathur_photo_profile

Abhishek Mathur

Senior Vice President & Head of R&D

Enzene Biosciences
India
Nick-Kotlarski_photo_profile

Nick Kotlarski

President & Chief Operating Officer

Bioworkshops
China
Sudeep Srivastava

Sudeep Srivastava

Senior Vice President

Biological E
India

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Edwin Simjaya

Edwin Simjaya

Head of Artificial Intelligence (AI) & Software Center

PT Kalbe Farma
Indonesia
Nikolai Petrovsky

Nikolai Petrovsky

Chairman & Research Director

Vaxine Pty Ltd
Australia
Nora Pataut

Nora Pataut

Programme Manager, Innovation & Manufacturing Technologies

GSK
Singapore
Rajat Bhasker

Rajat Bhasker

Project Management Leader & Head, Process Engineering

Novartis
Singapore
Sunil Gadekar

Sunil Gadekar

Director, MSAT, Advanced Therapies

Johnson & Johnson
Singapore
Vighnesh Kanagaraj

Vighnes Kanagaraj

Head, Transformation & Change

Pharmaniaga Berhad
Malaysia
Zach Pang

Zach Pang

Group Leader, Analytical Science & Technologies, Bioprocess Data Integration

A*STAR Bioprocessing Technology Institute
Singapore
Alois Jungbuer

Alois Jungbauer

Professor, Institute of Bioprocess Science and Engineering, Department of Biotechnology

University of Natural Resources and Life Sciences
Austria
Alok Mehrotra

Alok Mehrotra

Chief Quality Officer

Syngene International
India
Butet B Manurung

Butet B Manurung

Quality General Manager,

Kalbio Global Medika,
Indonesia
Ganeshan Varnakulasingham

Ganeshan Varnakulasingham

Chief Executive Officer

Sypharma
Australia
no-picture

John Mead

Chief Technology Officer

BioSouth
New Zealand
Jonggu-Kim_photo_profile

Jonggu Kim

External Manufacturing Large Molecules Gen Med & Vaccines Quality Leader,

Sanofi
South Korea
Krishnamurthy-Venkatesan_photo_profile

Krishnamurthy Venkatesan

Senior Director, MSAT

Biocon Biologics
Malaysia
Lucas-Chan_photo_profile

Lucas Chan

Scientific Founder & Chief Scientific Officer

CellVec
Singapore
Luo Shun

Luo Shun

Founder & President

Thousand Oaks Biopharmaceuticals
China
Min Zhu

Min Zhu

Senior Vice President, Technology & Manufacturing

Innoforce Pharmaceuticals
China
Nick-Kotlarski_photo_profile

Nick Kotlarski

President & Chief Operating Officer

Bioworkshops
China
Paul-McDonald_photo_profile

Paul McDonald

Chief Executive Officer

IDT
Australia
David James

Professor David James

Professor, Bioprocess Engineering & Research Centre Director

Advanced Biomanufacturing Centre, University of Sheffield
United Kingdom
Ravi-Ganapathy_photo_profile

Ravi Ganapathy

Director, R&D CMC

Hilleman Laboratories
Singapore
Scott-Wheelwright_photo_profile

Scott Wheelwright

Chief Operating Officer

BioInno Bioscience
China
Shireen_CRF_Photo (1) 1

Shireen Goh

Principal Scientist , Group Leader of Biomanufacturing Devices

A*STAR Bioprocessing Technology Institute
Singapore
Sudeep Srivastava

Sudeep Srivastava

Senior Vice President

Biological E
India
Xinfang Li

Xinfang Li

Chief Executive Officer

MabPlex
China
Zhang-Wei_photo_profile

Zhang Wei

Principal Scientist, Group Leader, Downstream Processing

A*STAR Bioprocessing Technology Institute
Singapore

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

END USER (CMOs Headquartered in Asia)
Super Early (By 8th March 2024)
SGD 1,795

Early (By 10th May 2024)
SGD 1,995 

Standard Price (By 12th July 2024)
SGD 2,095

Late Kate (By 10th September 2024)
SGD 2,295
Limited Group Packages
    • BUY2,GET3
    • BUY3,GET5
Solution Providers/BD/MKT (CMOs Headquartered Outside of Asia)
Super Early (By 8th March 2024)
SGD 3,595

Early (By 10th May 2024)
SGD 3,795 

Standard Price (By 12th July 2024)
SGD 3,995

Late Kate (By 10th September 2024)
SGD 4,095
Group Discount for Solution Providers & General Public: Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off
bcma-whats new
What's New?
  • Expect a bigger conference with Pioneers and Leaders shaping the Contract Manufacturing World with participation from regions covering APAC and beyond.

 

  • Bigger CMO Pavillion with more booths & representation from the region.

 

  • New Track on Biologics Digitalisation & AI covering the key aspects in biopharma automation, end-to-end.

 

  • Alongside the leading CMOs, meet the Digital Transformation, AI/ML leaders, IT experts and other key stakeholders at the conference sharing the success stories and paving the way to a smarter & efficient future.

 

  • The conference is held in conjunction with our Flagship Conference – 8th Cell & Gene Therapy World Asia 2024 with an additional track again on Cryogenics

 

CMO Pavilion

APAC CMO Pavilion 2024 aims to feature Biologics CMOs from the Asia Pacific Region, showcasing their company's services and solutions while representing their country exclusively.

Each country will be represented by one CMO organization, ensuring exclusivity and a prime location for business opportunities. The APAC CMO Pavilion offers a strategic platform to generate leads and promote companies effectively.

Some key features include strategically located booths and limited country representation, enhancing the value for exhibitors. Additionally, the co-location of this event with the 8th Annual Cell & Gene Therapy World Asia 2024, Biologics Digitalisation & AI World 2024, and Cryogenic Logistics World Asia 2024 provides a broader audience for CMOs to showcase their offerings.

Download the Sponsorship Prospectus Now!

Poster Presentation

The Poster Presentation Session at the prestigious 3rd Biologics Contract Manufacturing Asia 2024 in conjunction with Biologics Digitalisation World Asia 2024 conference provides pioneers in the field of biologics with a paramount platform for showcasing groundbreaking research, fostering collaboration, and advancing the frontier of biologics contract manufacturing & digitalisation in the dynamic Asian region.

The session promises to be a vibrant hub of knowledge exchange, where visionaries from diverse backgrounds converge to share their latest findings, innovative methodologies, and cutting-edge solutions. Whether you're an academic scholar or an industry expert, this is your opportunity to shine a spotlight on your work, gain valuable insights, and forge meaningful connections within the thriving biologics community.

Showcase your groundbreaking achievements to more than 600+ attendees that will be present at the conference.

Download the Event Brochure Now!

FEATURED CONTENT

Ebook website cover 900 x 480 2
Biologics Contract Manufacturing & Biologics Digitalisation - Survey Results
Ebook website cover 900 x 480 5
Biologics CMO Atlas: Navigating Biologics Contract Manufacturing in APAC
Screenshot-2023-06-01-150634
E-Book: Exclusive Conversations with Key Biologics CMOs in China
e0f666c4-4f55-4fb6-80c5-d94f55689fb7
BCMA 2023 Survey Results
speaker-feature-1-website
BCMA22 Speaker Interview 1

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

bcma-logo1-1
Biologics Contract Manufacturing Asia 2024 and Biologics Digitalization & AI World 2024

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Apply For Speaking Opportunity

Download Ebook

Download Featured Content Form

Download Ebook

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study- Biopharma Courier Service Provider